How CluePoints Detected Fraudulent Reporting of Investigational Product Administration from Patient Diary Data

Patient diaries are increasingly used in clinical trials to capture information such as outcomes or treatment intake directly from the patients. A pharmaceutical company was conducting a large phase III cardiovascular trial where information about Investigational Product administration by patients was collected at the sites before randomization and through patient diaries after randomization. The Sponsor was looking for a fast and efficient solution to detect potential issues at the study sites and in patient data. CluePoints was chosen to perform an overall data quality assessment of their data throughout the course of the trial. 

Complete the form to download the case study.

If you have any questions, please don't hesitate to contact us at